Troubles de stress post-traumatique : Questions médicales fréquentes
Nom anglais: Stress Disorders, Post-Traumatic
Descriptor UI:D013313
Tree Number:F03.950.750.500
Termes MeSH sélectionnés :
Multimorbidity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles de stress post-traumatique : Questions médicales les plus fréquentes",
"headline": "Troubles de stress post-traumatique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles de stress post-traumatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-11",
"dateModified": "2025-04-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles de stress post-traumatique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles de stress traumatique",
"url": "https://questionsmedicales.fr/mesh/D040921",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de stress traumatique",
"code": {
"@type": "MedicalCode",
"code": "D040921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.950.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Troubles de stress post-traumatique",
"alternateName": "Stress Disorders, Post-Traumatic",
"code": {
"@type": "MedicalCode",
"code": "D013313",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "John H Krystal",
"url": "https://questionsmedicales.fr/author/John%20H%20Krystal",
"affiliation": {
"@type": "Organization",
"name": "Clinical Neurosciences Division, United States Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, 300 George Street #901, New Haven, CT 06511, USA. Electronic address: john.krystal@yale.edu."
}
},
{
"@type": "Person",
"name": "Claudia Carmassi",
"url": "https://questionsmedicales.fr/author/Claudia%20Carmassi",
"affiliation": {
"@type": "Organization",
"name": "Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Italy."
}
},
{
"@type": "Person",
"name": "Liliana Dell'Osso",
"url": "https://questionsmedicales.fr/author/Liliana%20Dell%27Osso",
"affiliation": {
"@type": "Organization",
"name": "Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Italy."
}
},
{
"@type": "Person",
"name": "Jonathan I Bisson",
"url": "https://questionsmedicales.fr/author/Jonathan%20I%20Bisson",
"affiliation": {
"@type": "Organization",
"name": "Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, United Kingdom. Electronic address: bissonji@cardiff.ac.uk."
}
},
{
"@type": "Person",
"name": "Ilan Harpaz-Rotem",
"url": "https://questionsmedicales.fr/author/Ilan%20Harpaz-Rotem",
"affiliation": {
"@type": "Organization",
"name": "Clinical Neurosciences Division, United States Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, 300 George Street #901, New Haven, CT 06511, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Social determinants of multimorbidity patterns: A systematic review.",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/37050950",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1081518"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multimorbidity in patients with monoclonal gammopathy of undetermined significance.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36799553",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34476"
}
},
{
"@type": "ScholarlyArticle",
"name": "Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis.",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36094853",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acr.25020"
}
},
{
"@type": "ScholarlyArticle",
"name": "Costs of multimorbidity: a systematic review and meta-analyses.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35850686",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12916-022-02427-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors for multimorbidity in adulthood: A systematic review.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37647994",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.arr.2023.102039"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles liés aux traumatismes et au stress",
"item": "https://questionsmedicales.fr/mesh/D000068099"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles de stress traumatique",
"item": "https://questionsmedicales.fr/mesh/D040921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Troubles de stress post-traumatique",
"item": "https://questionsmedicales.fr/mesh/D013313"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles de stress post-traumatique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles de stress post-traumatique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles de stress post-traumatique",
"description": "Comment diagnostique-t-on le TSPT ?\nQuels critères sont utilisés pour le TSPT ?\nQui peut diagnostiquer le TSPT ?\nLe TSPT peut-il être confondu avec d'autres troubles ?\nQuels tests sont utilisés pour le TSPT ?",
"url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles de stress post-traumatique",
"description": "Quels sont les symptômes principaux du TSPT ?\nLe TSPT cause-t-il des problèmes de sommeil ?\nY a-t-il des symptômes émotionnels associés ?\nLe TSPT entraîne-t-il des problèmes de concentration ?\nLes symptômes du TSPT sont-ils constants ?",
"url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles de stress post-traumatique",
"description": "Peut-on prévenir le TSPT après un traumatisme ?\nQuels facteurs de protection existent contre le TSPT ?\nLes programmes de sensibilisation aident-ils ?\nLe soutien familial est-il important ?\nLes techniques de gestion du stress aident-elles ?",
"url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles de stress post-traumatique",
"description": "Quels traitements sont efficaces pour le TSPT ?\nLes médicaments sont-ils utilisés pour le TSPT ?\nLa thérapie de groupe est-elle bénéfique ?\nLe TSPT peut-il être traité par des approches alternatives ?\nCombien de temps dure le traitement du TSPT ?",
"url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles de stress post-traumatique",
"description": "Quelles complications peuvent survenir avec le TSPT ?\nLe TSPT augmente-t-il le risque de suicide ?\nLe TSPT peut-il affecter la santé physique ?\nLes troubles de l'usage de substances sont-ils fréquents ?\nLe TSPT peut-il affecter la vie professionnelle ?",
"url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles de stress post-traumatique",
"description": "Quels sont les facteurs de risque du TSPT ?\nLe sexe influence-t-il le risque de TSPT ?\nL'âge joue-t-il un rôle dans le TSPT ?\nUn antécédent de troubles mentaux augmente-t-il le risque ?\nLes événements traumatiques répétés augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le TSPT ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes et l'historique du patient."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le TSPT ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'exposition à un traumatisme et des symptômes persistants."
}
},
{
"@type": "Question",
"name": "Qui peut diagnostiquer le TSPT ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé mentale, comme un psychiatre ou un psychologue, peut diagnostiquer."
}
},
{
"@type": "Question",
"name": "Le TSPT peut-il être confondu avec d'autres troubles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec l'anxiété ou la dépression, nécessitant une évaluation approfondie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le TSPT ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de tests spécifiques, mais des questionnaires d'évaluation peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du TSPT ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des flashbacks, des cauchemars, et une hypervigilance."
}
},
{
"@type": "Question",
"name": "Le TSPT cause-t-il des problèmes de sommeil ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de TSPT peuvent souffrir d'insomnie ou de cauchemars fréquents."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes émotionnels associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des sentiments de colère, de tristesse ou de détachement émotionnel peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le TSPT entraîne-t-il des problèmes de concentration ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes peuvent éprouver des difficultés de concentration et de mémoire."
}
},
{
"@type": "Question",
"name": "Les symptômes du TSPT sont-ils constants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils peuvent fluctuer en intensité et être déclenchés par des rappels du traumatisme."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le TSPT après un traumatisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions précoces, comme le soutien psychologique, peuvent réduire le risque de TSPT."
}
},
{
"@type": "Question",
"name": "Quels facteurs de protection existent contre le TSPT ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon réseau de soutien social et des stratégies de coping efficaces peuvent aider."
}
},
{
"@type": "Question",
"name": "Les programmes de sensibilisation aident-ils ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes de sensibilisation peuvent informer sur le TSPT et ses traitements."
}
},
{
"@type": "Question",
"name": "Le soutien familial est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien familial peut jouer un rôle crucial dans la prévention et la récupération."
}
},
{
"@type": "Question",
"name": "Les techniques de gestion du stress aident-elles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation et le yoga peuvent réduire le stress post-traumatique."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour le TSPT ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie cognitivo-comportementale et les médicaments."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils utilisés pour le TSPT ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antidépresseurs et anxiolytiques peuvent être prescrits pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle bénéfique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie de groupe peut offrir un soutien et des stratégies de coping aux patients."
}
},
{
"@type": "Question",
"name": "Le TSPT peut-il être traité par des approches alternatives ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches comme la méditation et l'art-thérapie peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement du TSPT ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais peut durer plusieurs mois à plusieurs années selon les cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le TSPT ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la dépression, l'anxiété, et des problèmes relationnels."
}
},
{
"@type": "Question",
"name": "Le TSPT augmente-t-il le risque de suicide ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de TSPT ont un risque accru de pensées suicidaires et de tentatives."
}
},
{
"@type": "Question",
"name": "Le TSPT peut-il affecter la santé physique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le TSPT peut entraîner des problèmes de santé physique comme des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les troubles de l'usage de substances sont-ils fréquents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes atteintes de TSPT développent des troubles liés à l'usage de substances."
}
},
{
"@type": "Question",
"name": "Le TSPT peut-il affecter la vie professionnelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent interférer avec la concentration et la performance au travail."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du TSPT ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des événements traumatiques, l'historique familial et le stress."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de TSPT ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer un TSPT après un traumatisme que les hommes."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le TSPT ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes et les adolescents sont souvent plus vulnérables au TSPT."
}
},
{
"@type": "Question",
"name": "Un antécédent de troubles mentaux augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un antécédent de troubles mentaux peut accroître le risque de développer un TSPT."
}
},
{
"@type": "Question",
"name": "Les événements traumatiques répétés augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes exposées à des traumatismes répétés ont un risque plus élevé de TSPT."
}
}
]
}
]
}
Social determinants of multimorbidity are poorly understood in clinical practice. This review aims to characterize the different multimorbidity patterns described in the literature while identifying t...
Monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma, is present in over 5% of adults aged 70 and older, a population with a high prevalence of multimorbidity. MG...
To identify differences in multimorbidity and individual comorbidities among individuals with rheumatoid arthritis (RA), separated by race and ethnicity....
This case-control study within OptumLabs Data Warehouse from 2010 to 2019 matched RA cases (defined by 2 codes plus prescription of an RA drug) to non-RA controls 1:1 on age, sex, race and ethnicity, ...
We identified 154,391 RA cases and 154,391 controls (mean age 59.6, 76% female). Black enrollees had the most multimorbidity ≥2/≥5 (73.1%, 34.3%); Asian enrollees had the least (52.4%, 17.3%). Adjuste...
Multimorbidity is a problem for all RA patients. Targeted identification of certain comorbidities by race and ethnicity may be a helpful approach to mitigate multimorbidity....
Multimorbidity is a rising global phenomenon, placing strains on countries' population health and finances. This systematic review provides insight into the costs of multimorbidity through addressing ...
We conducted a systematic review (PROSPERO: CRD42020204871) of studies published from January 2010 to January 2022, which reported on costs associated with combinations of at least two specified condi...
Fifty-nine studies were included in the review, the majority of which were from high-income countries, particularly the United States. (1) Reported annual costs of multimorbidity per person ranged fro...
Multimorbidity imposes a large economic burden on both the health system and society, most notably for patients with cancer and mental health condition in the first year after cancer diagnosis. Whethe...
Multimorbidity, the coexistence of multiple chronic diseases in an individual, is highly prevalent and challenging for healthcare systems. However, its risk factors remain poorly understood....
To systematically review studies reporting multimorbidity risk factors....
A PRISMA-compliant systematic review was conducted, searching electronic databases (MEDLINE, EMBASE, Web of Science, Scopus). Inclusion criteria were studies addressing multimorbidity transitions, tra...
Of 20,806 identified studies, 68 were included, with participants aged 18-105 from 23 countries. Nine risk factor categories were identified, including demographic, socioeconomic, and behavioral facto...
Several risk factors seem to be consistently associated with an increased risk of accumulating chronic diseases over time. However, heterogeneity in settings, exposure and outcome, and baseline health...
It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effect...
The aim of this study will be evaluating the characteristics and ocurrence of AEs in multimorbid patients in hospitalised internal medicine patients of Estonia, and describes the development of a trig...
We will search for the evidence on measuring AEs in the population of multimorbid patients focusing on trigger tools, and synthesize the data. Data collection of the triggers from the literature will ...
Results will be disseminated to healthcare providers and stakeholders at national and international conferences, and as a doctoral medical thesis....
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respirat...
Multimorbidity poses an immense burden on the healthcare systems globally, whereas the management strategies and guidelines for multimorbidity are poorly established. We aim to synthesize current evid...
We searched four electronic databases (PubMed, Embase, Web of Science, and the Cochrane Database of Systematic Reviews). Systematic reviews (SRs) on interventions or management of multimorbidity were ...
A total of 30 SRs (464 unique underlying studies) were included, including 20 SRs of interventions and 10 SRs summarizing evidence on management of multimorbidity. Four categories of interventions wer...
Combined interventions for multimorbidity at different levels would be favored to promote different types of health outcomes. Challenges exist in the management at the patient, provider, and organizat...
Due to gaps in the literature, we developed a systematic method to assess multimorbidity using national surveys. The objectives of this study were thus to identify methods used to define and measure m...
We used the count method to define multimorbidity. We created a pre-defined list of disease conditions by examining international literature and using local data on the burden of disease. We assessed ...
Multimorbidity is typically associated with deficient health-related quality of life in mid-life, and the likelihood of developing multimorbidity in women is elevated. We address the issue of data spa...
The study focuses on a cohort of 4477 female patients, (aged 45-60) in Piedmont, Italy, and utilizes their multimorbidity data prior to the COVID-19 pandemic from their medical history from 2015 to 20...
From sparse data consisting of 174 input features, we have created a low-dimensional feature matrix of 17 features. Machine Learning algorithms are applied to the reduced sparsity-free data to predict...
Mapping higher-dimensional data to a low-dimensional space can result in information loss, but reducing sparsity can be beneficial for Machine Learning modeling due to improved predictive ability. In ...